Gold nanoparticles functionalized with 3-mercapto-1-propansulfonate (AuNPs-3MPS) have been prepared and loaded with Methotrexate (MTX), an immunosuppressive agent used in the systemic treatment of moderate-severe inflammatory diseases. The effects of the AuNPs-3MPS@MTX topically administered in vitro on skin model and in vivo on imiquimod-induced psoriasis-like mice model, have been studied. Clinical response, epidermal thickness, cell proliferation rate and inflammation were tested. AuNPs-3MPS@MTX treated mice showed a decreasing of scaling and erythema score, reduction of epidermal thickness, parakeratosis and hyperkeratosis, compared to AuNPs-3MPS treated mice. Immunohistochemistry analysis staining displayed that Ki67, K6 CD3 and CD8 stainings were reduced in AuNPs-3MPS@MTX treated mice. Blood evaluation showed no differences in blood count and in ALT and AST levels before and after AuNPs-3MPS or AuNPs-3MPS@MTX treatment. Topical AuNPs-3MPS@MTX treatment is able to induce a reduction of keratinocytes hyperproliferation, epidermal thickness and also inflammatory infiltrate in vivo on imiquimod-induced psoriasis like mice model.

Fratoddi, I., Benassi, L., Botti, E., Vaschieri, C., Venditti, I., Bessar, H., et al. (2019). Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. NANOMEDICINE, 17, 276-286 [10.1016/j.nano.2019.01.006].

Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model

Botti E.
Conceptualization
;
Venditti I.
Membro del Collaboration Group
;
Costanzo A.
Membro del Collaboration Group
;
Casagrande V.
Membro del Collaboration Group
;
Federici M.
Membro del Collaboration Group
;
Bianchi L.;
2019-01-01

Abstract

Gold nanoparticles functionalized with 3-mercapto-1-propansulfonate (AuNPs-3MPS) have been prepared and loaded with Methotrexate (MTX), an immunosuppressive agent used in the systemic treatment of moderate-severe inflammatory diseases. The effects of the AuNPs-3MPS@MTX topically administered in vitro on skin model and in vivo on imiquimod-induced psoriasis-like mice model, have been studied. Clinical response, epidermal thickness, cell proliferation rate and inflammation were tested. AuNPs-3MPS@MTX treated mice showed a decreasing of scaling and erythema score, reduction of epidermal thickness, parakeratosis and hyperkeratosis, compared to AuNPs-3MPS treated mice. Immunohistochemistry analysis staining displayed that Ki67, K6 CD3 and CD8 stainings were reduced in AuNPs-3MPS@MTX treated mice. Blood evaluation showed no differences in blood count and in ALT and AST levels before and after AuNPs-3MPS or AuNPs-3MPS@MTX treatment. Topical AuNPs-3MPS@MTX treatment is able to induce a reduction of keratinocytes hyperproliferation, epidermal thickness and also inflammatory infiltrate in vivo on imiquimod-induced psoriasis like mice model.
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/35 - MALATTIE CUTANEE E VENEREE
English
Functionalized gold nanoparticle; Methotrexate transepidermal delivery; Percutaneous delivery; Topical psoriasis treatment
Fratoddi, I., Benassi, L., Botti, E., Vaschieri, C., Venditti, I., Bessar, H., et al. (2019). Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. NANOMEDICINE, 17, 276-286 [10.1016/j.nano.2019.01.006].
Fratoddi, I; Benassi, L; Botti, E; Vaschieri, C; Venditti, I; Bessar, H; Samir, Ma; Azzoni, P; Magnoni, C; Costanzo, A; Casagrande, V; Federici, M; Bianchi, L; Pellacani, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 9.72 MB
Formato Adobe PDF
9.72 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/211259
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 45
social impact